The newborn eye imaging systems market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to healthcare accessibility and awareness, early disease detection initiatives, neonatal healthcare advancements, clinical studies and research, regulatory framework and guidelines.
The newborn eye imaging systems market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increased prevalence of prematurity, focus on early intervention, telemedicine and remote consultations, research and development investments, growing awareness and education. Major trends in the forecast period include collaborations and partnerships, continued research and clinical studies, personalized imaging and treatment plans, enhanced connectivity and data sharing, remote monitoring and telemedicine.
The newborn eye imaging systems market is expected to experience growth due to the rapidly increasing number of babies facing eye problems. Eye problems encompass various forms of vision loss, including total blindness, partial vision loss, and common eye-related defects in newborns. These issues can be congenital or acquired postnatally, with factors such as genetic abnormalities, intrauterine injury, maternal diabetes, and cocaine exposure contributing to ocular abnormalities. The demand for diagnosing and treating eye diseases in newborns is on the rise, leading to an increased need for newborn eye imaging systems. As of April 2022, the International Agency for the Prevention of Blindness reported that 448 million children and teenagers aged 0 to 19 were affected by refractive errors, with 90 million experiencing some degree of vision impairment. The escalating numbers of babies facing eye problems are a key driver behind the growth of the newborn eye imaging systems market.
The growth of the newborn eye imaging systems market is anticipated to be fueled by increasing healthcare expenditure. Healthcare expenditure refers to the total spending on healthcare-related goods and services within a specific period on a national or institutional level. Higher healthcare spending facilitates the acquisition of innovative diagnostic technologies such as newborn eye imaging systems. This ensures access to advanced equipment for early and precise diagnosis of eye conditions in newborns. According to the 2021-2030 National Health Expenditure report by the Centers for Medicare & Medicaid Services (CMS), national health spending is projected to grow by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. The increasing healthcare expenditure plays a crucial role in driving the growth of the newborn eye imaging systems market.
A significant trend in the newborn eye imaging systems market is the adoption of technological advancements. Leading companies in the market are focusing on the development of technologically advanced systems to maintain their market positions. For instance, in December 2022, NeoLight Newborn Care, a US-based medical device company, introduced the ROP Check software for digital care coordination in pediatric retinal screening. The ROP Check system ensures timely and standardized eye exams for eligible infants in the neonatal intensive care unit (NICU). It facilitates seamless management across various stakeholders, including patients, NICUs, ophthalmology specialists, and more.
Strategic partnerships are playing a key role in the newborn eye imaging systems market, with companies collaborating to enhance eye screening for children. In November 2022, Prada Group, an Italy-based luxury goods company, partnered with Vision+ Onlus, a non-profit organization in Italy promoting ophthalmic prevention programs. This collaboration aims to offer complimentary eye screenings for employees' children at Prada's Milan offices, as part of the 'Piccoli occhi da tenere d'occhio' initiative. The screening helps identify potential eye diseases and disorders at an early stage in preschool-age children.
In July 2022, ArchiMed, a France-based investment firm, acquired Natus Medical for $1.2 billion. Natus Medical, a US-based firm, offers solutions for screening, diagnosing, and treating disorders affecting the brain and sensory nervous systems, including newborn eye imaging systems. This acquisition positions Natus to bring advancements in the standard of care and enhance outcomes for patients affected by neurological disorders.
Major companies operating in the newborn eye imaging systems market include Natus Medical Incorporated, RetCam, Welch Allyn, Spectra Lab, EYE-PACS, Vantage Health, RetiVue, Eyenuk, iCare, Optos, Zeiss, Canon Medical Systems Corporation, Heidelberg Engineering, Leica Microsystems, Topcon, Avinger, Visionix, NIDEK, Bioptigen, DigitalOptics, Galatea Surgical, Luminera, D-EYE SRL, Visunex Medical Systems Inc., Intelligent Retinal Imaging Systems, Remidio Innovative Solutions Pvt. Ltd., Kowa American Corporation, Clarity Medical Systems Inc.
North America was the largest region in the newborn eye imaging systems market in 2024. The regions covered in the newborn eye imaging systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the newborn eye imaging systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Newborn eye imaging systems are medical technologies designed to detect congenital ocular defects shortly after a baby's birth, helping to prevent long-term vision loss in various disorders. These systems are utilized for a range of tests, including external eye examinations, red reflex tests, and fundus imaging performed by experienced ophthalmologists using wide-field digital retinal imaging systems.
These imaging systems play a crucial role in identifying diseases such as retinopathy of prematurity (ROP), retinal diseases, strabismus, refractive errors, color blindness, and other conditions. They come in various types, including basic devices and wireless devices. Retinopathy of prematurity (ROP) is a specific eye condition characterized by abnormal blood vessel growth in the retina, occurring in premature babies or those weighing less than 3 pounds at birth. The usage of newborn eye imaging systems extends to hospitals, ophthalmology diagnosis centers, ambulatory surgical centers, and other healthcare facilities.
The newborn eye imaging systems market research report is one of a series of new reports that provides newborn eye imaging systems market statistics, including newborn eye imaging systems industry global market size, regional shares, competitors with newborn eye imaging systems market share, detailed newborn eye imaging systems market segments, market trends, and opportunities, and any further data you may need to thrive in the newborn eye imaging systems industry. This newborn eye imaging systems market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The newborn eye imaging systems market consists of sales of scanning laser polarimetry (SLP), confocal scanning laser ophthalmoscopes (CSLO), optical coherence tomography (OCT) devices, and pediatric digital retinal imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The newborn eye imaging systems market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increased prevalence of prematurity, focus on early intervention, telemedicine and remote consultations, research and development investments, growing awareness and education. Major trends in the forecast period include collaborations and partnerships, continued research and clinical studies, personalized imaging and treatment plans, enhanced connectivity and data sharing, remote monitoring and telemedicine.
The newborn eye imaging systems market is expected to experience growth due to the rapidly increasing number of babies facing eye problems. Eye problems encompass various forms of vision loss, including total blindness, partial vision loss, and common eye-related defects in newborns. These issues can be congenital or acquired postnatally, with factors such as genetic abnormalities, intrauterine injury, maternal diabetes, and cocaine exposure contributing to ocular abnormalities. The demand for diagnosing and treating eye diseases in newborns is on the rise, leading to an increased need for newborn eye imaging systems. As of April 2022, the International Agency for the Prevention of Blindness reported that 448 million children and teenagers aged 0 to 19 were affected by refractive errors, with 90 million experiencing some degree of vision impairment. The escalating numbers of babies facing eye problems are a key driver behind the growth of the newborn eye imaging systems market.
The growth of the newborn eye imaging systems market is anticipated to be fueled by increasing healthcare expenditure. Healthcare expenditure refers to the total spending on healthcare-related goods and services within a specific period on a national or institutional level. Higher healthcare spending facilitates the acquisition of innovative diagnostic technologies such as newborn eye imaging systems. This ensures access to advanced equipment for early and precise diagnosis of eye conditions in newborns. According to the 2021-2030 National Health Expenditure report by the Centers for Medicare & Medicaid Services (CMS), national health spending is projected to grow by an average of 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. The increasing healthcare expenditure plays a crucial role in driving the growth of the newborn eye imaging systems market.
A significant trend in the newborn eye imaging systems market is the adoption of technological advancements. Leading companies in the market are focusing on the development of technologically advanced systems to maintain their market positions. For instance, in December 2022, NeoLight Newborn Care, a US-based medical device company, introduced the ROP Check software for digital care coordination in pediatric retinal screening. The ROP Check system ensures timely and standardized eye exams for eligible infants in the neonatal intensive care unit (NICU). It facilitates seamless management across various stakeholders, including patients, NICUs, ophthalmology specialists, and more.
Strategic partnerships are playing a key role in the newborn eye imaging systems market, with companies collaborating to enhance eye screening for children. In November 2022, Prada Group, an Italy-based luxury goods company, partnered with Vision+ Onlus, a non-profit organization in Italy promoting ophthalmic prevention programs. This collaboration aims to offer complimentary eye screenings for employees' children at Prada's Milan offices, as part of the 'Piccoli occhi da tenere d'occhio' initiative. The screening helps identify potential eye diseases and disorders at an early stage in preschool-age children.
In July 2022, ArchiMed, a France-based investment firm, acquired Natus Medical for $1.2 billion. Natus Medical, a US-based firm, offers solutions for screening, diagnosing, and treating disorders affecting the brain and sensory nervous systems, including newborn eye imaging systems. This acquisition positions Natus to bring advancements in the standard of care and enhance outcomes for patients affected by neurological disorders.
Major companies operating in the newborn eye imaging systems market include Natus Medical Incorporated, RetCam, Welch Allyn, Spectra Lab, EYE-PACS, Vantage Health, RetiVue, Eyenuk, iCare, Optos, Zeiss, Canon Medical Systems Corporation, Heidelberg Engineering, Leica Microsystems, Topcon, Avinger, Visionix, NIDEK, Bioptigen, DigitalOptics, Galatea Surgical, Luminera, D-EYE SRL, Visunex Medical Systems Inc., Intelligent Retinal Imaging Systems, Remidio Innovative Solutions Pvt. Ltd., Kowa American Corporation, Clarity Medical Systems Inc.
North America was the largest region in the newborn eye imaging systems market in 2024. The regions covered in the newborn eye imaging systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the newborn eye imaging systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Newborn eye imaging systems are medical technologies designed to detect congenital ocular defects shortly after a baby's birth, helping to prevent long-term vision loss in various disorders. These systems are utilized for a range of tests, including external eye examinations, red reflex tests, and fundus imaging performed by experienced ophthalmologists using wide-field digital retinal imaging systems.
These imaging systems play a crucial role in identifying diseases such as retinopathy of prematurity (ROP), retinal diseases, strabismus, refractive errors, color blindness, and other conditions. They come in various types, including basic devices and wireless devices. Retinopathy of prematurity (ROP) is a specific eye condition characterized by abnormal blood vessel growth in the retina, occurring in premature babies or those weighing less than 3 pounds at birth. The usage of newborn eye imaging systems extends to hospitals, ophthalmology diagnosis centers, ambulatory surgical centers, and other healthcare facilities.
The newborn eye imaging systems market research report is one of a series of new reports that provides newborn eye imaging systems market statistics, including newborn eye imaging systems industry global market size, regional shares, competitors with newborn eye imaging systems market share, detailed newborn eye imaging systems market segments, market trends, and opportunities, and any further data you may need to thrive in the newborn eye imaging systems industry. This newborn eye imaging systems market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The newborn eye imaging systems market consists of sales of scanning laser polarimetry (SLP), confocal scanning laser ophthalmoscopes (CSLO), optical coherence tomography (OCT) devices, and pediatric digital retinal imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Newborn Eye Imaging Systems Market Characteristics3. Newborn Eye Imaging Systems Market Trends and Strategies4. Newborn Eye Imaging Systems Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Newborn Eye Imaging Systems Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Newborn Eye Imaging Systems Market34. Recent Developments in the Newborn Eye Imaging Systems Market
5. Global Newborn Eye Imaging Systems Growth Analysis and Strategic Analysis Framework
6. Newborn Eye Imaging Systems Market Segmentation
7. Newborn Eye Imaging Systems Market Regional and Country Analysis
8. Asia-Pacific Newborn Eye Imaging Systems Market
9. China Newborn Eye Imaging Systems Market
10. India Newborn Eye Imaging Systems Market
11. Japan Newborn Eye Imaging Systems Market
12. Australia Newborn Eye Imaging Systems Market
13. Indonesia Newborn Eye Imaging Systems Market
14. South Korea Newborn Eye Imaging Systems Market
15. Western Europe Newborn Eye Imaging Systems Market
16. UK Newborn Eye Imaging Systems Market
17. Germany Newborn Eye Imaging Systems Market
18. France Newborn Eye Imaging Systems Market
19. Italy Newborn Eye Imaging Systems Market
20. Spain Newborn Eye Imaging Systems Market
21. Eastern Europe Newborn Eye Imaging Systems Market
22. Russia Newborn Eye Imaging Systems Market
23. North America Newborn Eye Imaging Systems Market
24. USA Newborn Eye Imaging Systems Market
25. Canada Newborn Eye Imaging Systems Market
26. South America Newborn Eye Imaging Systems Market
27. Brazil Newborn Eye Imaging Systems Market
28. Middle East Newborn Eye Imaging Systems Market
29. Africa Newborn Eye Imaging Systems Market
30. Newborn Eye Imaging Systems Market Competitive Landscape and Company Profiles
31. Newborn Eye Imaging Systems Market Other Major and Innovative Companies
35. Newborn Eye Imaging Systems Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Newborn Eye Imaging Systems Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on newborn eye imaging systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for newborn eye imaging systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The newborn eye imaging systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Disease Type: Retinopathy of Prematurity (ROP); Retinal Disease; Strabismus; Refractive Error; Color Blindness; Other Disease Types2) by Device Type: Basic Device; Wireless Device
3) by End User: Hospitals; Ophthalmology Diagnosis Centers; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) by Retinopathy of Prematurity (ROP): Screening and Diagnosis; Treatment Monitoring2) by Retinal Disease: Retinal Detachment; Diabetic Retinopathy
3) by Strabismus: Diagnostic Imaging; Treatment Assessment
4) by Refractive Error: Myopia; Hyperopia; Astigmatism
5) by Color Blindness: Diagnostic Testing; Screening Tools
6) by Other Disease Types: Congenital Eye Disorders; Ocular Infections
Key Companies Mentioned: Natus Medical Incorporated; RetCam; Welch Allyn; Spectra Lab; EYE-PACS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Newborn Eye Imaging Systems market report include:- Natus Medical Incorporated
- RetCam
- Welch Allyn
- Spectra Lab
- EYE-PACS
- Vantage Health
- RetiVue
- Eyenuk
- iCare
- Optos
- Zeiss
- Canon Medical Systems Corporation
- Heidelberg Engineering
- Leica Microsystems
- Topcon
- Avinger
- Visionix
- NIDEK
- Bioptigen
- DigitalOptics
- Galatea Surgical
- Luminera
- D-EYE SRL
- Visunex Medical Systems Inc.
- Intelligent Retinal Imaging Systems
- Remidio Innovative Solutions Pvt. Ltd.
- Kowa American Corporation
- Clarity Medical Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 2.21 Billion |
| Forecasted Market Value ( USD | $ 2.97 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
